Stock listing
ARTL Stock Price, News, Filings & Events — Artelo Biosciences, Inc.
Selected listing: ARTL · NASDAQ · USD · US
This page tracks Artelo Biosciences, Inc.'s ARTL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARTL:NASDAQ. ARTL:NASDAQ is the stock-level entry point for investors researching Artelo Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. The company has a market capitalization of approximately $3.56 million. Artelo focuses on developing innovative therapies, particularly in the field of cannabinoid-based treatments.
- Ticker
- ARTL:NASDAQ
- Asset type
- Stock
- Market cap
- $3.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Artelo Biosciences, Inc. ARTL:NASDAQ stock context
This page tracks Artelo Biosciences, Inc.'s ARTL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARTL:NASDAQ. ARTL:NASDAQ is the stock-level entry point for investors researching Artelo Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. The company has a market capitalization of approximately $3.56 million. Artelo focuses on developing innovative therapies, particularly in the field of cannabinoid-based treatments.
Research Artelo Biosciences, Inc.
Artelo Biosciences, Inc. investor report
Review AI stock analysis and investor report context for ARTL:NASDAQ.
Artelo Biosciences, Inc. company profile
View the public company page for Artelo Biosciences, Inc. on 6ix.
Artelo Biosciences, Inc. news
Read company news and market updates connected to Artelo Biosciences, Inc..
Artelo Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Artelo Biosciences, Inc..